| Y0200022 | 静脉注射用人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2003-01-10 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2003-04-15 | view |
| CSL20020052 | 静脉注射用人乙型肝炎免疫球蛋白 | | Injection | Biological Products(4) | New Drug Application | 2002-07-10 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2003-11-14 | view |
| CXSL1200085 | 静注肠病毒71型人免疫球蛋白(pH4) | | Other | Biological Products(1) | New Drug Application | 2013-03-13 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2015-01-07 | view |
| CXSL1600038 | 静注巨细胞病毒人免疫球蛋白(pH4) | | Other | Biological Products(7) | New Drug Application | 2016-06-12 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2016-12-08 | view |
| CXSL1000052 | 静注巨细胞病毒人免疫球蛋白(pH4) | | Other | Biological Products(7) | New Drug Application | 2010-12-23 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2013-03-22 | view |
| CXSL1600037 | 静注巨细胞病毒人免疫球蛋白 | | Other | Biological Products(7) | New Drug Application | 2016-06-12 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2016-12-08 | view |
| CYSB2200109 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-04-29 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2000276 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-11-11 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-29 | view |
| CYSB2000275 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-11-11 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | In Review | 2020-11-10 | view |
| CYSB2000274 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-11-11 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2021-10-29 | view |
| CYSB1900011 | 静注人免疫球蛋白（pH4、10%）（层析法） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2019-01-26 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | In Review | 2019-01-23 | view |
| CYSB0700044 | 静注人免疫球蛋白（pH4、10%） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2007-07-03 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2009-07-31 | view |
| CYSB2400114 | 静注人免疫球蛋白（pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2024-05-15 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2400412 | 静注人免疫球蛋白（pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2024-06-26 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB1400185 | 静注人免疫球蛋白(pH4、10%)(层析法) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2015-02-03 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2016-08-04 | view |
| CXSS1200023 | 静注人免疫球蛋白(pH4、10%) | human immunoglobulin(PH4) | Injection | Biological Products(7) | New Drug Application | 2013-05-31 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2016-03-10 | view |
| CYSB2101142 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2500020 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2025-01-17 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2101141 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2500019 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2025-01-17 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
